Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Artificial Intelligence In Cardiology Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The artificial intelligence in cardiology market has experienced substantial expansion in recent years. It is anticipated to expand from $2.72 billion in 2025 to $3.82 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 40.7%. This historic growth is attributable to several factors, including the increasing prevalence of cardiovascular diseases, the early adoption of cardiac imaging software, the rise of wearable medical devices, the need for quicker diagnoses, and the advancement of digital healthcare infrastructure.
The artificial intelligence in cardiology market size is anticipated to experience substantial growth over the next few years. It is expected to expand to $15.19 billion in 2030, achieving a compound annual growth rate (CAGR) of 41.2%. The increase during the forecast period can be attributed to the adoption of remote patient monitoring, AI driven clinical decision support, personalized cardiology treatments, the integration of telecardiology platforms, and a focused approach on preventive cardiac care. Major developments in the forecast period include AI based cardiac imaging analysis, the growth of predictive cardiology analytics, the integration of wearable heart monitoring, the automation of arrhythmia detection, and the expansion of remote cardiac care solutions.
Get A Free Sample Report With In-Depth Market Insights:
Artificial Intelligence In Cardiology Market Growth Catalysts And Demand Drivers
The significant prevalence of cardiovascular diseases is anticipated to accelerate the expansion of artificial intelligence within the cardiology market in the future. These conditions encompass all illnesses impacting the heart and blood vessels. AI finds application in cardiology for identifying cardiovascular diseases, aiding in the interpretation of electrocardiograms (ECGs), and pinpointing conditions such as long QT syndrome and atrial fibrillation. Furthermore, AI possesses the capability to analyze extensive datasets from electronic health records, mobile health devices, and medical imaging. For example, in August 2025, the American Cancer Society, a US-based non-profit organization, projected a 90.0% rise in cardiovascular prevalence between 2025 and 2050. Additionally, in October 2024, data from the Centres for Disease Control and Prevention (CDC), a US-based federal health agency, indicated that 919,032 individuals in the United States succumbed to cardiovascular disease in 2023, representing 1 in every 3 fatalities. Consequently, the widespread burden of cardiovascular diseases is propelling the growth of Artificial intelligence (AI) in Cardiology.
Artificial Intelligence In Cardiology Market Segment Analysis Spotlighting Growth Areas
The artificial intelligence in cardiology market covered in this report is segmented –
1) By Component: Hardware, Software Solutions, Services
2) By Application: Cardiac Arrhythmia, Stroke, Ischemic Heart Disease Or Coronary Artery Disease (CAD), Other Applications
3) By End-Use: Lifescience Companies, Healthcare Payers, Healthcare Providers
Subsegments:
1) By Hardware: Imaging Devices, Wearable Devices, Diagnostic Equipment
2) By Software Solutions: Cardiac Imaging Analysis Software, Predictive Analytics Tools, Patient Management Systems, Telemedicine Platforms
3) By Services: Consulting Services, Integration And Implementation Services, Maintenance And Support Services, Training And Education Services
Artificial Intelligence In Cardiology Market Trends Shaping Long-Term Demand
Leading companies operating within the artificial intelligence in cardiology market are primarily focusing on strategic collaborations to significantly advance heart research. These strategic partnerships involve a process where entities leverage each other’s strengths and resources to achieve mutual benefits and success. For example, in October 2023, the Icahn School of Medicine at Mount Sinai, a US-based medical school, announced a collaborative effort with Chiba Institute of Technology (CIT), a Japan-based private university. This partnership between the two universities intends to enhance knowledge, mitigation, and management of cardiovascular disease, while also creating novel methodologies to address this critical global health concern. Mount Sinai and CIT plan to collaborate on establishing worldwide clinical studies that integrate artificial intelligence with interventional cardiology, heart failure, cardiac electrophysiology, cardiac imaging, and preventive cardiology. The research will also place emphasis on minimizing gender and race prejudice at the intersection of artificial intelligence and cardiovascular research, aiming to improve patient care and results.
Artificial Intelligence In Cardiology Market Leading Companies: Who Holds The Strongest Market Presence?
Major companies operating in the artificial intelligence in cardiology market are Microsoft Corporation; International Business Machines Corporation; Siemens Healthineers; Koninklijke Philips; Ultromics Ltd; Bay Labs; Cleerly Inc.; RSIP Vision Ltd.; Idoven; Cardiologs Technologies Inc.; Viz.ai; Aidoc; Arterys Inc.; Zebra Medical Vision; AliveCor; DiA Imaging Analysis; Eko Health Inc.; Cardiomatics; UltraSight; Anumana Inc.; CardiAI Inc.; Caption Health Inc.; HeartFlow Inc.; iRhythm Technologies Inc.; Biofourmis Inc.
View The Full Artificial Intelligence In Cardiology Market Report:
Artificial Intelligence In Cardiology Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the artificial intelligence in cardiology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cardiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
